Citigroup Inc Sop Hi A Genetics Sa Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Citigroup Inc holds 15 shares of SOPH stock, worth $55. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$55
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SOPH
# of Institutions
42Shares Held
20.2MCall Options Held
1KPut Options Held
500-
Generation Investment Management LLP London, X06.79MShares$24.9 Million0.11% of portfolio
-
Banque Pictet & Cie Sa2.24MShares$8.23 Million0.05% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$8.21 Million0.07% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.2MShares$8.07 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$7.95 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $235M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...